Identification of a Role for the Ventral Hippocampus in Neuropeptide S-Elicited Anxiolysis

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Dine, Julien ^a   Ionescu, Irina A ^a   Stepan, Jens ^a   Yen, Yi Chun ^a   Holsboer, Florian ^a   Landgraf, Rainer ^a   Eder, Matthias ^a   Schmidt, Ulrike ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; DENTATE GYRUS; FACILITATION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; MOUSE; NERVE CELL PLASTICITY; NERVE POTENTIAL; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANQUILIZING ACTIVITY; VENTRAL HIPPOCAMPUS;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; NEUROPEPTIDES; SYNAPTIC TRANSMISSION;

MUS;

EID: 84875493494     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060219     Document Type: Article

References (49)

1. Griebel G, Holsboer F, (2012) Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? Nat Rev Drug Discov 11: 462-478.
2. Hokfelt T, Bartfai T, Bloom F, (2003) Neuropeptides: opportunities for drug discovery. Lancet Neurol 2: 463-472.
3. Leonard SK, Dwyer JM, Sukoff Rizzo SJ, Platt B, Logue SF, et al. (2008) Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders. Psychopharmacology (Berl) 197: 601-611.
4. Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, et al. (2004) Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43: 487-497.
5. Ionescu IA, Dine J, Yen YC, Buell DR, Herrmann L, et al. (2012) Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons. Neuropsychopharmacology 37: 1323-1337.
6. Lukas M, Neumann ID, (2012) Nasal application of neuropeptide S reduces anxiety and prolongs memory in rats: social versus non-social effects. Neuropharmacology 62: 398-405.
7. Jungling K, Seidenbecher T, Sosulina L, Lesting J, Sangha S, et al. (2008) Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala. Neuron 59: 298-310.
8. Xu YL, Gall CM, Jackson VR, Civelli O, Reinscheid RK, (2007) Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. J Comp Neurol 500: 84-102.
9. Adhikari A, Topiwala MA, Gordon JA, (2010) Synchronized activity between the ventral hippocampus and the medial prefrontal cortex during anxiety. Neuron 65: 257-269.
10. Kjelstrup KG, Tuvnes FA, Steffenach HA, Murison R, Moser EI, et al. (2002) Reduced fear expression after lesions of the ventral hippocampus. Proc Natl Acad Sci U S A 99: 10825-10830.
11. Satpute AB, Mumford JA, Naliboff BD, Poldrack RA, (2012) Human anterior and posterior hippocampus respond distinctly to state and trait anxiety. Emotion 12: 58-68.
12. Windle RJ, Gamble LE, Kershaw YM, Wood SA, Lightman SL, et al. (2006) Gonadal steroid modulation of stress-induced hypothalamo-pituitary-adrenal activity and anxiety behavior: role of central oxytocin. Endocrinology 147: 2423-2431.
13. De Kloet ER, Rotteveel F, Voorhuis TA, Terlou M, (1985) Topography of binding sites for neurohypophyseal hormones in rat brain. Eur J Pharmacol 110: 113-119.
14. Jinno S, Kosaka T, (2003) Patterns of expression of neuropeptides in GABAergic nonprincipal neurons in the mouse hippocampus: quantitative analysis with optical disector. J Comp Neurol 461: 333-349.
15. Hajizadeh Moghaddam A, Hosseini RS, Roohbakhsh A, (2012) Anxiogenic effect of CCK8s in the ventral hippocampus of rats: possible involvement of GABA(A) receptors. Pharmacol Rep 64: 45-53.
16. Gross CT, Canteras NS, (2012) The many paths to fear. Nat Rev Neurosci 13 (9) (): 651-8.
17. Kim MJ, Gee DG, Loucks RA, Davis FC, Whalen PJ, (2011) Anxiety dissociates dorsal and ventral medial prefrontal cortex functional connectivity with the amygdala at rest. Cereb Cortex 21: 1667-1673.
18. Myers-Schulz B, Koenigs M, (2012) Functional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders. Mol Psychiatry 17: 132-141.
19. Shin LM, Liberzon I, (2010) The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35: 169-191.
20. Duangdao DM, Clark SD, Okamura N, Reinscheid RK, (2009) Behavioral phenotyping of neuropeptide S receptor knockout mice. Behav Brain Res 205: 1-9.
21. Zhu H, Mingler MK, McBride ML, Murphy AJ, Valenzuela DM, et al. (2010) Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1. Psychoneuroendocrinology 35: 1119-1132.
22. Okamura N, Habay SA, Zeng J, Chamberlin AR, Reinscheid RK, (2008) Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor. J Pharmacol Exp Ther 325: 893-901.
23. Trapella C, Pela M, Del Zoppo L, Calo G, Camarda V, et al. (2011) Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). J Med Chem 54: 2738-2744.
24. Franklin K, Paxinos G (2007) The mouse brain in stereotaxic coordinates with CDROM. New York, NY, USA: Academic Press.
25. Bunck M, Czibere L, Horvath C, Graf C, Frank E, et al. (2009) A hypomorphic vasopressin allele prevents anxiety-related behavior. PLoS One 4: e5129.
26. Schmidt MV, Schulke JP, Liebl C, Stiess M, Avrabos C, et al. (2011) Tumor suppressor down-regulated in renal cell carcinoma 1 (DRR1) is a stress-induced actin bundling factor that modulates synaptic efficacy and cognition. Proc Natl Acad Sci U S A 108: 17213-17218.
27. Maggio N, Segal M, (2007) Striking variations in corticosteroid modulation of long-term potentiation along the septotemporal axis of the hippocampus. J Neurosci 27: 5757-5765.
28. Fanselow MS, Dong HW, (2010) Are the dorsal and ventral hippocampus functionally distinct structures? Neuron 65: 7-19.
29. Refojo D, Schweizer M, Kuehne C, Ehrenberg S, Thoeringer C, et al. (2011) Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science 333: 1903-1907.
30. von Wolff G, Avrabos C, Stepan J, Wurst W, Deussing JM, et al. (2011) Voltage-sensitive dye imaging demonstrates an enhancing effect of corticotropin-releasing hormone on neuronal activity propagation through the hippocampal formation. J Psychiatr Res 45: 256-261.
31. Stepan J, Dine J, Fenzl T, Polta SA, von Wolff G, et al. (2012) Entorhinal theta-frequency input to the dentate gyrus trisynaptically evokes hippocampal CA1 LTP. Front Neural Circuits 6: 64.
32. Rizzi A, Vergura R, Marzola G, Ruzza C, Guerrini R, et al. (2008) Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice. Br J Pharmacol 154: 471-479.
33. Airan RD, Meltzer LA, Roy M, Gong Y, Chen H, et al. (2007) High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 317: 819-823.
34. Luo L, Callaway EM, Svoboda K, (2008) Genetic dissection of neural circuits. Neuron 57: 634-660.
35. Bremner JD, Licinio J, Darnell A, Krystal JH, Owens MJ, et al. (1997) Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry 154: 624-629.
36. Hauger RL, Risbrough V, Oakley RH, Olivares-Reyes JA, Dautzenberg FM, (2009) Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann N Y Acad Sci 1179: 120-143.
37. Manns JR, Eichenbaum H, (2006) Evolution of declarative memory. Hippocampus 16: 795-808.
38. Meis S, Bergado-Acosta JR, Yanagawa Y, Obata K, Stork O, et al. (2008) Identification of a neuropeptide S responsive circuitry shaping amygdala activity via the endopiriform nucleus. PLoS One 3: e2695.
39. Meis S, Stork O, Munsch T, (2011) Neuropeptide S-mediated facilitation of synaptic transmission enforces subthreshold theta oscillations within the lateral amygdala. PLoS One 6: e18020.
40. Andersen P, Morris R, Amaral D, Bliss T, O'Keefe J, editors (2007) The hippocampus book. New York: Oxford University Press.
41. Malinow R, (2003) AMPA receptor trafficking and long-term potentiation. Philos Trans R Soc Lond B Biol Sci 358: 707-714.
42. Clark SD, Duangdao DM, Schulz S, Zhang L, Liu X, et al. (2011) Anatomical characterization of the neuropeptide S system in the mouse brain by in situ hybridization and immunohistochemistry. J Comp Neurol 519: 1867-1893.
43. Pape HC, Pare D, (2010) Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol Rev 90: 419-463.
44. Somerville LH, Wagner DD, Wig GS, Moran JM, Whalen PJ, et al. (2012) Interactions between transient and sustained neural signals support the generation and regulation of anxious emotion. Cereb Cortex 23 (1) (): 49-60.
45. Etkin A, (2010) Functional neuroanatomy of anxiety: a neural circuit perspective. Curr Top Behav Neurosci 2: 251-277.
46. Bannerman DM, Grubb M, Deacon RM, Yee BK, Feldon J, et al. (2003) Ventral hippocampal lesions affect anxiety but not spatial learning. Behav Brain Res 139: 197-213.
47. Castro AA, Moretti M, Casagrande TS, Martinello C, Petronilho F, et al. (2009) Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: a comparative study with amphetamine and diazepam. Pharmacol Biochem Behav 91: 636-642.
48. Pacheco R, Pescador BB, Mendonca BP, Ramos SF, Guerrini R, et al. (2011) Role of the ecto-nucleotidases in the cooperative effect of adenosine and neuropeptide-S on locomotor activity in mice. Pharmacol Biochem Behav 99: 726-730.
49. Reinscheid RK, (2008) Neuropeptide S: anatomy, pharmacology, genetics and physiological functions. Results Probl Cell Differ 46: 145-158.